AKARI THERAPTC Stock Price (NASDAQ:AKTX)

Add to My Stocks
$2.33 $0.03 (1.27%) AKTX stock closing price Feb 21, 2018 (Closing)
Prev Close* : $2.36
Market Cap:
$27.79M
Day Low: $2.32
52 Week Low: $2.06
Open: $2.36
Volume: -
Day High: $2.41
52 Week High: $22.20
Dividend:
0.00

Latest Stock Market News

Latest Articles

AKARI THERAPTC News - From Partners

AKTX Stockcharts

View AKTX PE ratio, PS ratio stocks charts and compare with peers.
AKTX Chart
Note: Compare AKARI THERAPTC stock price history with the index and industry peers.

AKARI THERAPTC Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
-999.0000
PB ratio (
price to book ratio
)
-999.0000

AKARI THERAPTC Returns

ROE
(return on equity)

AKARI THERAPTC Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity
Dividend Yield
-999.0000

AKTX Industry Peers

Company Price Change (%)
Oncobiologics (ONS)1.160.01 (0.85%)
Eleven Biotherapeutics (EBIO)0.940.01 (1.08%)
Flex Pharma (FLKS)4.280.1 (2.39%)
Chemocentryx (CCXI)9.70.4 (4.3%)
Receptos (RCPT)231.960.03 (0.01%)
Emergent Biosolutions (EBS)49.661.04 (2.14%)
Ambit Biosciences (AMBI)15.60 (0%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Fate Therapeutics (FATE)10.591.42 (15.49%)
NeoGenomics (NEO)8.080.72 (9.78%)
Sunesis Pharma (SNSS)6.990.62 (9.73%)
Compugen (CGEN)3.250.2 (6.56%)
Fortress Biotech (FBIO)3.630.21 (6.14%)
Alder BioPharma (ALDR)14.550.7 (5.05%)
Stemline Therapeutics (STML)16.550.75 (4.75%)
Top gainers from Medical-Biomed-Genetics industry
* As of Feb 22, 2018
CompanyPriceChange (%)
GTx (GTXI)15.461.25 (7.48%)
Catalyst Biosciences (CBIO)27.541.96 (6.64%)
Five Prime Therapeutics (FPRX)17.681.21 (6.41%)
Arbutus Biopharma (ABUS)5.250.25 (4.55%)
Ultragenyx Pharma (RARE)46.311.87 (3.88%)
MediciNova (MNOV)10.610.4 (3.63%)
The Medicines Company (MDCO)31.621.18 (3.6%)
Top losers from Medical-Biomed-Genetics industry
* As of Feb 22, 2018

Akari Therapeutics PLC (ADR) Stock News - Partner Headlines

AKARI THERAPTC Financial Statements

income statement20162015201420132012
Net Sales or Revenues-----
Net Income-18.14M-45.31M-9.64M-3.62M-4.26M
Total Operating Expense27.24M30.57M10.17M3.6M3.66M
View AKARI THERAPTC income statement
balance sheet20162015201420132012
Total Assets45.87M69.89M6.48M7.83M1.12M
Total Liabilities11.77M21.17M1.62M2.01M4.48M
Shareholders Equity34.1M48.71M4.85M5.81M-3.36M
View AKARI THERAPTC balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) in Assets Liabilities-1.45M4.67M--1.88M2.03M
Net Cash from (used by) Operating Activities-24.62M-4.96M-9.46M-5.45M-2.13M
Increase (Decrease) in Prop Plant And Equipment-0.05M-0.01M-0.05M--
View AKARI THERAPTC cash flow statement

AKARI THERAPTC Stock Message Board

As of last trading day, AKARI THERAPTC stock price was $2.33. Looking at AKARI THERAPTC market capitalization, which currently stands at $27.79M, we can say that AKTX stock is a Nano Cap stock. Investors can use valuation multiples like the P/E ratio, price to sales ratio etc. for performing AKARI THERAPTC stock analysis.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that AKARI THERAPTC is worth a lot, it will most likely be reflected in an inflated AKARI THERAPTC stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. 102,073 shares were traded with a closing stock price of $2.33 as of Feb 21, 2018, as can be seen from AKARI THERAPTC stock quote. One can view AKARI THERAPTC stock chart to follow the stock price trend. A dividend is a cash payment made from a company's earnings and is distributed among shareholders. AKARI THERAPTC does not pay dividends. AKARI THERAPTC stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.